Skip to Main Content
Centers for Disease Control and Prevention link     Centers for Disease Control & Prevention and Emergency Preparedness & Response Centers for Disease Control and Prevention link CDC Smallpox Home
Smallpox Vaccination and Adverse Events Training Module - Reactions Links & Site Map Adverse Reactions link Normal Reactions link All Reactions link Site Map link
Side Navigation Menu & Copyright 2002 CDC/HHS Home Page link Smallpox link About the Vaccine link Contraindications link Vaccination Method link Preventing Contact Transmission link Vaccinia Immune Globulin link; Laboratory Testing link Continuing Education link Contact link

Generalized Vaccinia: Frequency & Susceptible Populations

Frequency link Pathogenesis link Clinical Link Diagnosis link Management link Prevention link General Info link Generalized Vaccinia Menu  
Click here to Zoom History unknown, extensive generalized vaccinia lesions
Back  1 of   Next    Zoom    View All

Click on image to enlarge



Report Adverse Event link Report Adverse Event link

Generalized Vaccinia (GV) Cases per 1,000,000 Primary Vaccinations(*)


Age (yrs) 1968 National
Survey(†)

1968 10-State
Survey(§¶)

1-4 17.6 258.7
5-19 11.7 157.2
>20 45.1 242.4
Totals >1 yr 17.5 222.8

The 1968 Ten State Survey rates may be over estimates as generalized vaccinia was often confused with other, non-specific immune mediated rashes, such as erythema multiforme, that can occur following vaccination.

* Numbers rounded to the nearest tenth, total number of vaccinations estimated in both studies. Observations missing age were distributed according to the existing age distribution for GV.
Case sources include: American Red Cross Vaccinia Immune Globulin (VIG) distribution system, Red Cross VIG consultants, State and Territorial Epidemiologists, Burroughs-Wellcome Thiosemicarbazone distribution list, smallpox vaccine manufacturers complication reporting files, state reports to the Encephalitis Surveillance Unit of the National Communicable Disease Center (NCDC), and specimen submissions for vaccinia testing to the Viral Exanthems Unit of NCDC.
§ Case sources include: Physician reporting via survey in 10 states with active case information follow-up and chart review for post-vaccinial encephalitis and vaccinia necrosum reports.
Rates may be overestimates as generalized vaccinia was often confused with other, non-specific immune-mediated rashes, such as erythema multiforme, that can occur following vaccination.


Susceptible Populations

Since most of these individuals are children, and most were seen and studied at a time when immunologic knowledge was less complete than at present, characteristics that enhance susceptibility are not known for certain. It is likely that many of these children had subtle and minor immunologic abnormalities that permitted some extension of virus spread, but not morbid or lethal disease.



Accidental Administration link Inadvertent Inoculation link Bacterial Infection link Congenital Vaccinia link Eczema Vaccinatum link Encephalitis link Erythema Multiforme link Generalized Vaccinia link Normal Primary link Normal Variants link Progressive Vaccinia link Vaccinia Keratitis link Revaccination link All Reactions links